AKT1 Mouse Monoclonal Capture Antibody [Clone ID: OTI2B9]

CAT#: TA600055

AKT1 mouse monoclonal capture antibody, validated for ELISA and Luminex assays

Product Images

AKT1 ELISA with 2D9 Capture (TA600055) and 4C11 Detection (TA700055) Antibodies. Substrate used: Recombinant Human AKT1 (TP320257)

• 

  AKT1 Luminex with 2B9 Capture (TA600055) and 4G4 Detection (TA700077) Antibodies. Substrate used: Recombinant Human AKT1 (TP320257)

• 

  AKT1 Luminex with 2B9 Capture (TA600055) and 4C11 Detection (TA700055) Antibodies. Substrate used: Recombinant Human AKT1 (TP320257)

Specifications

Product Data

• Clone Name: OTI2B9
• Applications: ELISA, LMNX
• Recommended Dilution: 1:100 - 1:1000
• Reactivities: Human, Mouse, Rat
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Immunogen: Full length human recombinant protein of human AKT1 (NM_005163) produced in HEK293T cell.
• Formulation: Stored in PBS (pH 7.4) containing 0.05% sodium azide and up to 5% trehalose
• Concentration: 0.5 mg/ml
• Conjugation: Unconjugated
• Storage: Store at -20°C.
  Avoid repeat freeze/thaw cycles.
• Stability: Stable for 12 months from date of receipt.
• Gene Name: AKT serine/threonine kinase 1
• Database Link:
  NP_005154
  Entrez Gene 11651 MouseEntrez Gene 24185 RatEntrez Gene 207 Human
  UniProt ID P31749
• Synonyms: AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA
• Matched ELISA Pair: TA700055, TA700077

Reference Data

• Protein Families: Druggable Genome, ES Cell Differentiation/IPS, Protein Kinase
• Protein Pathways: Acute myeloid leukemia, Adipocytokine signaling pathway, Apoptosis, B cell receptor signaling pathway, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, Glioma, Insulin signaling pathway, Jak-STAT signaling pathway, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Renal cell carcinoma, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Toll-like receptor signaling pathway, VEGF signaling pathway